COMPASS THERAPEUTICS INC
CMPXNASDAQ🏆 #3839 by market capEarnings Nov 11US Equity
$0.76▼ $0.00 (−0.54%)
🌙 After hours$0.78▲ 3.15%Regular close · extended-hours price shownTrack CMPX
Get earnings, price moves & breaking news on Telegram
24h▼ 0.5%
7d▼ 5.9%
14d▼ 15.5%
30d▼ 30.6%
ytd▼ 85.9%
1y▼ 79.9%
🏦Market Cap
$136M
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
—
Otter Score
—
Insufficient data
COMPASS THERAPEUTICS INC
CMPXAnalyst Ratings
Price
$0.7562
Total
17
Raised
2
Lowered
1
Avg PT
$4.67
H / L
$6 / $4
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Craig-Hallum | Reiterated | Buy | 2026-09-23 | $15.00 | +1883.60% |
HC Wainwright & Co. | Reiterated | Buy | 2026-09-23 | — | — |
Wedbush | Downgraded | Outperform → Neutral | 2026-09-23 | $4.00 | +429.00% |
Guggenheim | Reiterated | Buy | 2026-09-23 | $4.00 | +429.00% |
Citizens | Reiterated | Market Outperform | 2026-09-23 | — | — |
Piper Sandler | Reiterated | Overweight | 2026-08-07 | — | — |
Canaccord Genuity | Reiterated | Buy | 2026-04-28 | $13.00 | +1619.10% |
D. Boral Capital | Reiterated | Buy | 2026-04-27 | — | — |
Leerink Partners | Upgraded | Market Perform → Outperform | 2025-04-02 | $6.00 | +693.40% |
Jefferies | Reiterated | Buy | 2025-02-10 | $9.00 | +1090.20% |
Ladenburg Thalmann | Upgraded | Neutral → Buy | 2024-09-16 | — | — |
Stifel | Reiterated | Buy | 2023-01-27 | — | — |
EF Hutton | Reiterated | Buy | 2022-12-16 | — | — |
Raymond James | Reiterated | Outperform | 2022-11-10 | $9.00 | +1090.20% |
SVB Leerink | Reiterated | Outperform | 2022-05-05 | — | — |
B. Riley Securities | Reiterated | Buy | 2022-01-19 | — | — |
Roth Capital | Reiterated | Buy | 2021-11-19 | — | — |
Institution
Craig-Hallum
Reiterated · Buy · 2026-09-23
$15.00
+1883.60%
HC Wainwright & Co.
Reiterated · Buy · 2026-09-23
—
—
Wedbush
Downgraded · Outperform → Neutral · 2026-09-23
$4.00
+429.00%
Guggenheim
Reiterated · Buy · 2026-09-23
$4.00
+429.00%
Citizens
Reiterated · Market Outperform · 2026-09-23
—
—
Piper Sandler
Reiterated · Overweight · 2026-08-07
—
—
Canaccord Genuity
Reiterated · Buy · 2026-04-28
$13.00
+1619.10%
D. Boral Capital
Reiterated · Buy · 2026-04-27
—
—
Leerink Partners
Upgraded · Market Perform → Outperform · 2025-04-02
$6.00
+693.40%
Jefferies
Reiterated · Buy · 2025-02-10
$9.00
+1090.20%
Ladenburg Thalmann
Upgraded · Neutral → Buy · 2024-09-16
—
—
Stifel
Reiterated · Buy · 2023-01-27
—
—
EF Hutton
Reiterated · Buy · 2022-12-16
—
—
Raymond James
Reiterated · Outperform · 2022-11-10
$9.00
+1090.20%
SVB Leerink
Reiterated · Outperform · 2022-05-05
—
—
B. Riley Securities
Reiterated · Buy · 2022-01-19
—
—
Roth Capital
Reiterated · Buy · 2021-11-19
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space